Skip to main content
PYXS
NASDAQ Life Sciences

MICVO Response Rate Rises to 39% as Pyxis Plots Mid-2027 Phase 3

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.46
Mkt Cap
$168.647M
52W Low
$1.03
52W High
$5.55
52W Position info
42% above low
Off High info
74% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

PYXS sits 42% above its 52-week low of $1.03.

Summary

Updated Phase 1 data for MICVO in 2L+ R/M HNSCC show a 39% confirmed response rate in 33 evaluable patients as of October 14, 2026, up from the 36% cORR reported in September. Median response duration came in at 9.2 months and median PFS at 6.7 months, which the company frames as a 50% improvement over patients' most recent prior therapy. No new Grade 3 peripheral neuropathy cases were reported, and six patients with prior Grade 3 events improved — a safety update that matters for a drug meant to be used earlier in treatment. The company plans to start a global Phase 3 trial in mid-2027; more mature overall survival data are expected in the first half of 2027. This is still a small, early-stage cohort, so the read is encouraging but not confirmatory.

At the time of this announcement, PYXS was trading at $1.46 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $168.6M. The 52-week trading range was $1.03 to $5.55. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

PYXS - Latest Insights

PYXS
Nov 13, 2026, 4:17 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.58
Real-time Price: $1.45 info
Change: -$0.130 (-8%) info
Market Cap: $168.647M info
PYXS
Nov 05, 2026, 7:45 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.65
Real-time Price: $1.45 info
Change: -$0.200 (-12%) info
Market Cap: $168.647M info
PYXS
Nov 05, 2026, 7:39 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.65
Real-time Price: $1.45 info
Change: -$0.200 (-12%) info
Market Cap: $168.647M info
PYXS
Nov 05, 2026, 7:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.65
Real-time Price: $1.45 info
Change: -$0.200 (-12%) info
Market Cap: $168.647M info
PYXS
Oct 21, 2026, 4:27 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $1.79
Real-time Price: $1.45 info
Change: -$0.340 (-19%) info
Market Cap: $168.647M info